Bumadizone

DB13286ApprovedSmall molecule

Bumadizone has been approved for use in Germany and Austria, it is a drug with anti-inflammatory, antipyretic, and analgesic properties, and was marketed for the treatment of both rheumatoid arthritis... Its use is restricted to these conditions, due to risks this drug poses.

Formula / weight: C₁₉H₂₂N₂O₃ · 326.396 g/mol (avg)

Resolves to

Compound

UNIIATD81G944MCAS3583-64-0ChEMBLCHEMBL2105456ChEBI76119

Clinical / RWD

RxNorm19847ATCM01AB07

Structure

InChIKeyFLWFHHFTIRLFPV-UHFFFAOYSA-NSMILESCCCCC(C(O)=O)C(=O)N(NC1=CC=CC=C1)C1=CC=CC=C1

What you can answer from here — as of February 21, 2021

1,392Drug interactionsStructured to mechanism, not free text

1ATC codeIncluding every combination product, plus 17 drug categories

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of Bumadizone, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account